tiprankstipranks
Lisata Therapeutics (LSTA)
NASDAQ:LSTA
Holding LSTA?
Track your performance easily

Lisata Therapeutics (LSTA) Income Statement

1,029 Followers

Lisata Therapeutics Income Statement

Last quarter (Q3 2024), Lisata Therapeutics's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Lisata Therapeutics's net income was $-4.93M. See Lisata Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
------
Cost of Revenue
------
Gross Profit
------
Operating Expense
$ 23.48M$ 25.71M$ 57.60M$ 29.05M$ 19.14M$ -20.09M
Operating Income
$ -23.48M$ -25.71M$ -57.60M$ -29.05M$ -19.14M$ -20.09M
Net Non Operating Interest Income Expense
------
Other Income Expense
$ -1.95M$ 2.54M$ 897.00K$ -76.00K$ -132.00K$ -740.00K
Pretax Income
$ -21.54M$ -23.17M$ -56.70M$ -28.97M$ -19.01M$ -19.35M
Tax Provision
$ -798.00K$ -2.33M$ -2.48M$ -1.51M$ -10.87M$ -1.94M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -20.74M$ -20.84M$ -54.23M$ -27.47M$ -8.15M$ -19.36M
Basic EPS
$ -2.51$ -2.58$ -10.47$ -7.50$ -7.95-
Diluted EPS
$ -2.51$ -2.58$ -10.47$ -7.50$ -7.95$ -28.20
Basic Average Shares
$ 33.07M$ 8.07M$ 5.18M$ 3.69M$ 1.03M$ 688.33K
Diluted Average Shares
$ 33.07M$ 8.07M$ 5.18M$ 3.69M$ 1.03M$ 686.56K
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 11.44M$ 25.71M$ 57.60M$ 29.05M$ 19.14M$ -20.09M
Net Income From Continuing And Discontinued Operation
$ -20.74M$ -20.84M$ -54.23M$ -27.47M$ -8.15M$ -19.36M
Normalized Income
$ -9.87M--$ -30.48M--
Interest Expense
------
EBIT
$ -16.57M$ -25.71M$ -57.60M$ -29.05M$ -19.14M$ -19.35M
EBITDA
$ -16.29M$ -25.52M$ -57.53M$ -29.00M$ -19.08M$ -19.05M
Currency in USD

Lisata Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis